Literature DB >> 28468866

Retraction: Proteasome Inhibition Blocks NF-κB and ERK1/2 Pathways, Restores Antigen Expression, and Sensitizes Resistant Human Melanoma to TCR-Engineered CTLs.

.   

Abstract

Entities:  

Year:  2017        PMID： 28468866      PMCID： PMC5973486          DOI： 10.1158/1535-7163.MCT-17-0084

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN： 1535-7163            Impact factor:   6.261


× No keyword cloud information.
  2 in total

1.  Proteasome inhibition blocks NF-κB and ERK1/2 pathways, restores antigen expression, and sensitizes resistant human melanoma to TCR-engineered CTLs.

Authors:  Ali R Jazirehi; James S Economou
Journal:  Mol Cancer Ther       Date:  2012-04-24       Impact factor: 6.261

2.  Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.

Authors:  Ali R Jazirehi; Stavroula Baritaki; Richard C Koya; Benjamin Bonavida; James S Economou
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.